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Background. The epidemiological impact of public health interventions targeted at reducing transmission of
human immunodeficiency virus type 1 (HIV-1) during early or late-stage infection depends on the contribution of
these disease stages to transmission within a particular epidemic.
Methods. Transmission hazards and durations of periods of high infectivity during primary, asymptomatic, and
late-stage infection were estimated for HIV-1–serodiscordant heterosexual couples in Rakai, Uganda, by use of a
robust probabilistic framework.
Results. Primary infection and late-stage infection were estimated to be 26 and 7 times, respectively, more
infectious than asymptomatic infection. High infectiousness during primary infection was estimated to last for 3
months after seroconversion, whereas high infectiousness during late-stage infection was estimated to be concen-
trated between 19 months and 10 months before death.
Conclusions. Primary and late-stage HIV-1 infection are more infectious than previously estimated, but for
shorter periods. In a homogeneous population, the asymptomatic stage of infection will typically contribute more to
the net transmission of HIV-1 over the lifetime of an infected individual, because of its longer duration. The depen-
dence of the relative contribution of infectious stages on patterns of sexual behavior and the phase of epidemics is
discussed.
The early (primary) and late stages of HIV-1 infection
have long been known to be associated with high rates of
transmission, because of the high viral loads observed
for these periods [1–4]. The relative infectiousness dur-
ing each stage of HIV-1 infection has previously been
estimated by examining viral load changes [5], fitting
epidemic models to incidence data [6–11], estimating
relative risks from limited studies [12, 13], and extrapo-
lating from transmission estimates based on transmis-
sion as a function of viral load [14–16]. The relative
contribution of early infection to transmission has been
estimated using epidemic models [8, 10, 17–19] and by
phylogenetic clustering of samples from early and
chronic infection [20–23]. The phylogenetic studies
suggest that chains or groups of transmission associated
with primary infection play an important role in trans-
mission within these cohorts, which are predominately
made up of men who have sex with men (MSM). How-
ever, inevitably partial sampling of the population
means that these methods cannot directly quantify the
relative proportion of transmissions during each stage,
particularly because the proportions will change during
the course of an epidemic [7, 8, 10, 19, 24].
In 2005,Wawer et al. [25] published extensive empir-
ical data from a cohort in Rakai, Uganda, that quantified
how transmission within stable partnerships between
heterosexuals varies by stage of infection. This landmark
study presents the best available data from which to di-
rectly estimate both the relative transmissibility of
HIV-1 during each stage of infection and the duration of
periods of high infectiousness. Wawer and colleagues
estimated that, during the first 5months of infection, the
probability of transmission per coital act was 8–10 times
higher than during asymptomatic infection and that the
probability of transmission also increased by 4–8-fold
during the 2 years before death. For a person newly in-
fected outside of the partnership, the probability of in-
fecting their long-term partner within2.5months was
43%. However, only 10–13 (15%–20%) of 66 transmis-
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sions observed in this study can be said to have occurred during
primary infection. These data have led some authors to propose
that a large proportion of HIV-1 transmissions occur during
primary infection [26, 27], whereas others have emphasized that
because of its short duration, particularly compared with the
duration of asymptomatic infection, primary infection may be
responsible for23% of transmissions [28].
Although the data presented byWawer et al. [25] are ground-
breaking, the methods they used to interpret their observations
included a number of unnecessary simplifications. First, because
the probability of transmission per coital act was estimated as the
number of transmissions divided by the number of reported
coital acts in a given observation interval, coital acts that oc-
curred after transmission were not discounted. Second, these
estimates relied on accurate reporting of numbers of coital acts,
but previous analysis has shown the difficulty of interpreting
data on the reported number of coital acts [29, 30] and convert-
ing the probability of transmission per coital act into the rate of
transmission per partnership per unit of time [31, 32]. Here,
within a clearly defined probabilistic framework, we estimate the
hazard (i.e., rate) of transmission as a function of time since the
partnership was first observed. Third,Wawer et al. [25] assumed
that incident infection and death of the seropositive partner oc-
curred halfway through the 10-month observation interval in
which they took place. We instead consider these as unknown
hidden events, such that infection and death have an equal prob-
ability of occurring at each possible time under study. Finally,
the duration of periods of high infectivity were not estimated by
Wawer and colleagues but instead were assumed to be multiples
(or quarter/half multiples) of the observation interval. In our
inference framework, we use the Rakai data to estimate both
transmission rates and the duration of the periods of high infec-
tiousness. The opportunities for transmission in each stage of
infection are determined not only by the infectiousness of each
stage but also by their length.
It is not possible to directly translate the relative infectiousness
during each stage of infection throughout an infected individu-
al’s lifetime into the contribution of that individual to an epi-
demic at any particular point in an epidemic, because of varia-
tion in risk behavior and population epidemic dynamics. The
number of new infections caused by an infected individual dur-
ing an average life span in a fully susceptible population, also
known as the basic reproduction number R0, is a useful policy
tool in designingHIV-1–control programs.R0 predicts themag-
nitude of effort required to control transmission during an epi-
demic, as well as the likely impact of preventing transmission
during the different stages of infection. The estimation of R0 is
complicated by its dependence on the sexual mixing network,
and thusR0 may vary by population, subpopulation, and setting.
To provide a measure of a range of possible outcomes, we esti-
mate R0 for populations characterized by 2 extremes of sexual
behavior, namely random mixing and serial monogamy.
The main goals of this analysis were to estimate the hazard of
transmission and the duration of highHIV-1 transmissibility for
each stage of HIV-1 infection, both of which contribute to the
infectiousness during each stage. We consider our estimates to
be more reliable and informative than those previously pub-
lished and note that the estimates of the relative infectiousness
during different disease stages are very different from findings of
previous analyses of these data.We discuss the impact of variable
infectiousness on the epidemiology and transmission dynamics
of HIV-1 by estimating R0, and we outline the public health im-
plications of our estimates.
SUBJECTS AND METHODS
HIV-1-serodiscordant couples in the Rakai study were observed
at 10-month observation intervals and their serostatus recorded
[25]. The incident infection group consisted of HIV-1–serodis-
cordant couples in which both partners were seronegative at the
beginning of an observation period and at least 1 of the persons
in the couple seroconverted by the endof the observation period.
The late-stage infection group consisted of HIV-1–serodiscor-
dant couples in which the seropositive partner died during the
study. The prevalent infection group consisted of HIV-1–
serodiscordant couples in which the seropositive partner had
infection throughout the observation period.
Seroconversion was detected using immunoassays, with dis-
cordant samples and new HIV-1 seroconversions confirmed by
Western blot analysis [25]. Fiebig et al. [33] have shown that
these assays can detect infection within 2–4 weeks after HIV-1
acquisition and that this interval is fairly consistent across indi-
viduals. We therefore assume that observing the time between
seroconversion of the index partner and seroconversion of the
initially seronegative partner is equivalent to observing the time
between onset of their respective infections.
Of the 23 couples who were serodiscordant immediately be-
fore the death of the index partner, 13 were followed up, and
none contained a partner who seroconverted. A decrease in the
frequency of sexual activity before death of the index partner
[25], probably because of AIDS-associated symptoms, is the
most likely explanation for the lack of seroconversions. Data
obtained after the death of the index partner were not used by
Wawer et al. [25] because many of the surviving partners were
lost to follow-up. Because more than half of the at-risk partners
were followed up in our study and because all of them were
seronegative, we considered this to be an important observation
and included follow-up data from these subjects in our analysis.
We assume that the hazard profile (s) for transmission dur-
ing primary infection, asymptomatic infection, and the period
immediately before death is a function of the time since infection
s and is of the form illustrated in figure 1. The probability of
transmission during each observation period is then calculated
and fitted to the observed data by maximizing the likelihood
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(appendix, which appears only in the electronic edition of the
Journal).
To illustrate the contribution of each stage of infection to
transmission under the 2 extremes of sexual behavior, we for-
mulated expressions for R0 for moderate rates of partner change
(i.e., serialmonogamy) and for very high rates of partner change,
resulting in random contacts between individuals (appendix).
RESULTS
The estimated transmission parameters are given in table 1. The
transmission rate during different disease stages are shown in
figure 2A. From this best-fit model, the predicted proportion of
individuals being infected is shown in figure 2B and compared
with the data. The inferred transmission parameters indicate
that (1) the period of high transmissibility during primary infec-
tion lasts 3months, (2)HIV-1 is 26 timesmore infectious during
primary infection than during the asymptomatic period, (3) the
hazard during asymptomatic infection is 10.6 transmissions per
100 person-years, (4) the transmission rate 19–10 months be-
fore death is 7 times higher than that during asymptomatic in-
fection, and (5) the transmission rate during the final 10months
before death is zero.
The R0 calculations show that HIV-1 transmission can barely
be sustained in populations in which the risk of transmission is
relatively low (R0  1.09 for the serialmonogamy scenario) (ta-
ble 2). The reproduction number and resulting epidemic growth
rate are higher for a population in which people make random
contacts (R0  2.15). The relative contribution of the asymp-
tomatic stage to the transmission of HIV-1 is higher in the serial
monogamy scenario than in the random mixing scenario (71%
vs. 42%), although this stage represents the largest proportion of
infections in both scenarios.
DISCUSSION
Wehave robustly estimated both the hazard of transmission and
the duration of periods of high transmissibility ofHIV-1 by stage
of infection, using a statistical model that fits the observed data
well (figure 2A). The estimated relative transmission hazard dur-
ing primary infection is significantly higher than the relative
transmission rate previously estimated from these data [25].
Comparison with transmission rates as a function of viral load
estimated elsewhere [34] indicates that the transmission rate
during primary infection is significantly higher than would be
expected on the basis of the plasma viral loads observed during
these periods, with no overlap of confidence intervals (figure 3).
Figure 1. Transmission rates over the course of an HIV-1 infection
[compare 1, 4, 6–9]. During the period of primary infection (dp), the
transmission rate (p) is very high. During the asymptomatic period, the
transmission rate () is assumed to be constant. During the 10–19-month
period before death (dA), the transmission rate (A) is again high. Imme-
diately before death, there is a short interval (d0) during which no
transmission occurs, because the infected partner being so unhealthy
that sexual contact is limited.
Table 1. Hazards of HIV-1 transmission and durations of high infectiousness, by infection stage.
Parameter Description Value (95% CI)
Primary infection
p Transmission hazard per 100 person-years 276 (131–509)
dp Duration of stage, months 2.90 (1.23–6.00)
PP Probability of transmission if in a monogamous partnership, % 49 (27–70)
Asymptomatic infection
 Transmission hazard, cases per 100 person-years 10.6 (7.61–13.3)
P year Probability of transmission per 12-month duration of monogamy, % 10
Before death
A Transmission hazard, cases per 100 person-years 76.0 (41.3–128)
dA Duration of high transmission risk before death, months 9.00 (4.81–14.0)
d0 Duration of no transmission risk before death, months 10.0 (6.97–12.7)
PP Probability of transmission if in a monogamous partnership, % 43 (27–62)
NOTE. Transmission hazards and durations were estimated from data reported by Wawer et al. [25]. Parameters are illustrated in
figure 1. The probability of transmission, if in a single partnership throughout the stage, is also given as Pi  1  e-˜id˜i, where ˜i is the
transmission hazard per year, and d˜i is the duration of the stage in years. CI, univariate confidence interval.
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Transmission rates before death are also higher than those that
would be expected as a result of high plasma viral loads during
this period (figure 3). The reasons for these higher than expected
transmission rates should be further investigated; coinfection
with other sexually transmitted pathogens is a likely cause of
enhanced infectiousness during primary infection, but this has
not been conclusively demonstrated.
Our estimate of 2.9months of high infectivity during primary
infection suggests coincidence with the 2–3-month period of
high viral loads observed in patients [37]. The duration of AIDS
ismore variable and is highly dependent on the characteristics of
population studied, the AIDS-defining event, and the popula-
tion’s geographic location, ranging from3months to2 years in
SouthAfrica [38], Europe [39], and Thailand [40] and averaging
9.2 months in Uganda [41]. Our estimate of 19 months (95%
confidence interval, 12–27 months) falls between these clinical
estimates. The relationship between the timing of both high
transmission rates 10–19 months before death and limited sex-
ual behavior before death (during the final 10months of life) and
known virological, immunological, or clinical markers during
late-stage infection is not identified here and merits further in-
vestigation.
Estimates of the role of each stage of infection in transmission
are sensitive not only to the relative infectiousness during each
stage, but also to sexual behavior and the phases of an epidemic
[7, 8, 10, 19, 24]. Mathematical models of HIV-1 transmission
have long included variable infectiousness at the different stages
of disease [1, 4–7, 9, 19], usually within frameworks similar to
that illustrated in figure 1. The relative importance of different
disease stages to the overall incidence of infection is intimately
tied up with epidemic dynamics. Early in a novel outbreak, a
large proportion, perhaps even the majority, of new infections
are transmitted from persons with primary infection, irrespec-
tive of how infectious the primary stage of infection is. As the
epidemic progresses, relatively more individuals enter later
stages of infection, and thus the proportion of new infections
acquired from persons with later-stage disease increase, again
irrespective of their actual infectiousness.
To estimate the lifetime contribution of each stage to trans-
mission, we calculated R0 for serially monogamous and random
mixing scenarios (table 2). The long duration of the asymptom-
atic stage allows many opportunities for transmission in both
sexual behavior scenarios despite the low relative hazard of
transmission. Increased levels of testing, resulting in earlier di-
agnosis, counseling, and treatment, have the potential to dra-
matically reduce transmission during this long period of de-
creased infectivity [17, 27, 44].
HIV-1 in persons with primary infection is highly infectious
and may result in clusters of transmission in high-risk popula-
tions in which individuals have many sexual contacts per unit
time, as illustrated here, or if there are high levels of concurrency
[42, 43]. In serially monogamous populations, transmission
during primary infection only occurs if HIV-1 is acquired in a
partnership, the partnership breaks up, and a new partnership is
formed within the 3-month window of high infectivity, which
reduces the contribution of onward transmission (table 2).
The period of high infectivity before death plays a larger role
in lifelong transmission in high-risk populations than in less sex-
ually active populations (0.57 vs. 0.21 new infections) because of
the increased number of contacts during this relatively short
period of high infectiousness (table 2). A diagnosismade years or
even a fewmonths before late-stage infection has the potential to
limit transmission during the period of increased infectivity in
the final months before death.
Our relatively simple estimates of R0 do not consider complex
sexual networks, age-dependent increases, or decreases in sexual
activity, stratified risk behavior, concurrent partnerships, or po-
lygamous relationships, which have been shown to affect trans-
Figure 2. Fitted probabilities of transmission and estimated parame-
ters. A, Graphical representation of the transmission parameters and
duration of each stage for the best-fit parameters (table 1). B, Comparison
between the proportion of serodiscordant partners who seroconverted
during each observation interval in the study published by Wawer et al.
[25] (grey bars), with binomial trial 95% confidence intervals, and the
fitted probability of transmission in each observation interval for the best
fit parameters. Note that the duration of the third incident observation
interval is 20 months.
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mission dynamics [8, 10, 43, 45, 46]. Even under more-complex
sexual mixing scenarios, transmission during primary infection
and late-stage infection is constrained by the short duration of
these periods.
Couples in the Rakai cohort were counseled and provided
with condoms [25], which may have reduced the frequency of
unprotected sex, leading to underestimates of transmission rates
in the wider population. Higher frequencies of unprotected sex
within partnerships may be straightforwardly included in our
framework by scaling the transmission rates by a constant factor,
thus increasing the basic reproduction number while keeping
the relative roles of each stage of infection inHIV-1 transmission
similar. Thus, we conclude that our analysis provides a robust
assessment of the relative contribution of different stages of in-
fection to transmission yet remains cautious about extrapolating
these findings to total transmission levels.
The transmission rates estimated here are also almost cer-
tainly an underestimate of transmission rates for partnerships
between MSM or for injection drug users, because transmission
probabilities per contact for these modes of transmission have
been shown to be higher than that for vaginal sex.
The inferences drawn in our study from the data presented by
Wawer and colleagues have some limitations: there may have
been a selection bias in themiddle and late-stage partnerships in
this cohort for discordant couples who had not yet serocon-
verted; male-to-female and female-to-male transmission rates
may be different, although previous analysis of this cohort has
found no significant difference [25, 36]; and variability in risk
behavior could not be studied because of the small sample size. It
has also been suggested that transmission events could have oc-
curred outside the studied sexual partnership or by another
method [47]. However, Wawer et al. [25] selected sexual part-
ners and performed analyses to confirm the epidemiological link
between transmitting and newly infected partners.
A major conclusion of our study is that there is substantial
potential for transmission to occur during the asymptomatic
and late stages of infection and that interventions targeted at
reducing transmission during these periods have the potential to
have a large impact on an epidemic. For populations in which
there is a moderately high rate of testing or high awareness of
Figure 3. Comparison between transmission rates as a function of
viral load and during each stage of infection. Comparison between the
transmission rates expected from the blood plasma HIV-1 RNA viral loads
observed in each stage of infection and the actual transmission rates in
each stage. The transmission rate as a function of viral load as derived
by Fraser et al. [34] from data from the study published by Fideli et al. [35]
is shown as a solid line with confidence intervals as a dotted line. The
mean transmission rate for this cohort is 10.6 per 100 person-years. The
transmission rates by stage estimated here are shown as points with
their confidence intervals as vertical lines. These transmission rates are
placed on the graph according to published mean viral loads during this
period: primary infection,100 million HIV-1 RNA copies per mL of blood
plasma [33]; asymptomatic infection, 12,500 HIV-1 RNA copies per mL
of blood plasma (mean viral load in study of the Rakai cohort by Quinn
et al. [36]); and AIDS, 162,000 copies per mL of blood plasma [37]. In
the cohort analyzed by Wawer et al. [25], the average viral load observed
before the index partner’s death was 112,600 copies per mL of blood
(5.05 log copies per mL of blood).
Table 2. Calculation of the basic reproduction number (R0), according to the contribution from each stage of HIV-1
infection, under 2 extremes of sexual behavior.
Infection
stage
Hazard of transmission
() per person-year
Duration of high infectiousness
(d )/interval between seroconversion
and deatha (%), mean, years
No. (%) of new transmissions,
by sexual behaviorb
Serial monogamy Random mixing
Primary 2.76 0.24/10.2 (2) 0.10 (9) 0.67 (31)
Asymptomatic 0.106 8.38c/10.2 (82) 0.77 (71) 0.91 (42)
AIDS 0.760 0.75d/10.2 (16) 0.21 (20) 0.57 (27)
R0 . . . . . . 1.09 (100) 2.15 (100)
a The mean interval between seroconversion and death (10.2 years) was adopted from the report by Morgan et al. [48].
b The formula for calculating the number of new transmissions in a scenario of serial monogamy is cd/(  c  1/d ), where c is 1.25 partner
changes/year. The formula in a scenario of random mixing is d (appendix).
c d was calculated by subtracting the mean durations of the periods of high transmissibility during primary infection (0.24 years) and AIDS (0.75
years) and the mean duration of zero transmission risk before death (0.83 years) from the mean interval between seroconversion and death (10.2
years).
d d corresponds to the period 10–19 months before death during which  was greatest for this infection stage.  was zero during the
10-month period immediately before death.
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risk, together with high levels of access to successful antiretrovi-
ral therapy, transmission during these later stagesmay already be
partially contained. Under these conditions, the proportion of
transmissions frompersons with primary infectionwill increase,
and initiatives aimed at identifying and possibly treating early
infectionmay be an important addition to rather than a replace-
ment for existing public health programs. For high-prevalence
populations in which diagnosis currently occurs late during in-
fection, increased rates of testing by means of relatively rapid
tests (which do not identify primary infection), combined with
reductions in transmission through changes in behavior and ad-
herence to treatment, have the potential to have a significant
impact on the epidemic.
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